Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Santos

Showing results (21-30 of 1,528) with videos related to

Pageof 153
Sort By:
Journal of the American College of Cardiology|March 18, 2014
Lipoprotein(a) and cardiovascular disease in heterozygous familial hypercholesterolemia: should we also blame the LDL receptor?Raul D Santos
Arteriosclerosis, Thrombosis, and Vascular Biology|February 23, 2018
Expression of LDLRs (Low-Density Lipoprotein Receptors), Dyslipidemia Severity, and Response to PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Homozygous Familial Hypercholesterolemia: Connecting the DotsRaul D Santos
European Journal of Preventive Cardiology|October 4, 2017
Better health literacy can make the difference when control of risk factors for cardiovascular disease and quality of life are concernedRaul D Santos
Annals of Internal Medicine|March 15, 2016
Review: PCSK9 inhibitors reduce mortality but increase neurocognitive events in hypercholesterolemiaRaul D Santos
Current Opinion in Lipidology|November 3, 2017
Genetics and molecular biology controversies on Mendelian randomization and proprotein convertase subtilisin-kexin type 9 inhibitor clinical trials: more data still necessaryRaul D Santos
Lancet (London, England)|April 3, 2025
Therapy for mixed dyslipidaemia through ANGPTL3 inhibitionRaul D Santos
American Journal of Preventive Cardiology|June 15, 2026
Potential of oral combination lipid‑lowering therapy beyond statins: a simulation‑based perspective from the SANTORINI studyRaul D Santos
Circulation. Cardiovascular Imaging|June 21, 2022
Coronary Artery and Thoracic Aorta Calcification and Cardiovascular Events in Severe Hypercholesterolemia: More Wood for the Cardiovascular Disease Risk Heterogeneity Bonfire!Raul D Santos
Atherosclerosis|March 22, 2016
Homozygous familial hypercholesterolemia: phenotype rules!Raul D Santos
Arquivos Brasileiros De Cardiologia|January 10, 2006
[Pharmacology of niacin or nicotinic acid]Raul D Santos
Pageof 153

Showing results (21-30 of 1,528) with videos related to

Sort By:
Pageof 153
Journal of the American College of Cardiology|March 18, 2014
Lipoprotein(a) and cardiovascular disease in heterozygous familial hypercholesterolemia: should we also blame the LDL receptor?Raul D Santos
Arteriosclerosis, Thrombosis, and Vascular Biology|February 23, 2018
Expression of LDLRs (Low-Density Lipoprotein Receptors), Dyslipidemia Severity, and Response to PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Homozygous Familial Hypercholesterolemia: Connecting the DotsRaul D Santos
European Journal of Preventive Cardiology|October 4, 2017
Better health literacy can make the difference when control of risk factors for cardiovascular disease and quality of life are concernedRaul D Santos
Annals of Internal Medicine|March 15, 2016
Review: PCSK9 inhibitors reduce mortality but increase neurocognitive events in hypercholesterolemiaRaul D Santos
Current Opinion in Lipidology|November 3, 2017
Genetics and molecular biology controversies on Mendelian randomization and proprotein convertase subtilisin-kexin type 9 inhibitor clinical trials: more data still necessaryRaul D Santos
Lancet (London, England)|April 3, 2025
Therapy for mixed dyslipidaemia through ANGPTL3 inhibitionRaul D Santos
American Journal of Preventive Cardiology|June 15, 2026
Potential of oral combination lipid‑lowering therapy beyond statins: a simulation‑based perspective from the SANTORINI studyRaul D Santos
Circulation. Cardiovascular Imaging|June 21, 2022
Coronary Artery and Thoracic Aorta Calcification and Cardiovascular Events in Severe Hypercholesterolemia: More Wood for the Cardiovascular Disease Risk Heterogeneity Bonfire!Raul D Santos
Atherosclerosis|March 22, 2016
Homozygous familial hypercholesterolemia: phenotype rules!Raul D Santos
Arquivos Brasileiros De Cardiologia|January 10, 2006
[Pharmacology of niacin or nicotinic acid]Raul D Santos
Pageof 153